巴曲酶联合依达拉奉在脑卒中治疗中的效果
The effect of batroxobin combined with edaravone in the treatment of stroke
ES评分 0
| DOI |
10.12208/j.ijim.20220010 |
| 刊名 |
International Journal of Internal Medicine
|
| 年，卷(期) |
2022, 3(1) |
| 作者 |
|
| 作者单位 |
大连市金州区第一人民医院 辽宁大连 ;
|
| 摘要 |
分析巴曲酶联合依达拉奉在脑卒中治疗中的效果。方法 入组本院2019年1月-2020年12月收治的脑卒中患者共60例，随机分组，单药组的患者使用的药物是巴曲酶，观察组则在单药组的基础上增加依达拉奉。比较效果。结果 观察组神经功能缺损评分低于单药组，生活质量得分、神经元特异性烯醇化酶、血浆纤维蛋白原、炎性指标均优于单药组，疗效高于单药组，P＜0.05。两组不良反应对比没有明显差异， P＞0.05。结论 巴曲酶与依达拉奉双联药物对于脑卒中的治疗作用更为确切，安全性高。
|
| Abstract |
Objective To analyze the effect of batroxobin combined with edaravone in the treatment of stroke. Methods A total of 60 stroke patients admitted to our hospital from January 2019 to December 2020 were enrolled and randomly divided into groups. The drug used by the patients in the single-drug group was batroxobin, and the observation group was treated with batroxobin on the basis of the single-drug group. Add edaravone. Compare effects. Results The neurological deficit score of the observation group was lower than that of the single-drug group, the quality of life score, neuron-specific enolase, plasma fibrinogen, and inflammatory indexes were better than those of the single-drug group, and the curative effect was higher than that of the single-drug group, P< 0.05. There was no significant difference in adverse reactions between the two groups, P>0.05. Conclusion Batroxobin and edaravone dual drugs have more precise and high safety in the treatment of stroke.
|
| 关键词 |
巴曲酶；依达拉奉；脑卒中；治疗效果
|
| KeyWord |
Batroxobin; Edaravone; Stroke; Therapeutic Effect
|
| 基金项目 |
|
| 页码 |
37-39 |
刘微微*.
巴曲酶联合依达拉奉在脑卒中治疗中的效果 [J].
国际内科前沿杂志.
2022; 3; (1).
37 - 39.